SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-352943
Filing Date
2011-12-27
Accepted
2011-12-27 16:35:01
Documents
1
Period of Report
2011-12-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d273938d8k.htm 8-K 11867
  Complete submission text file 0001193125-11-352943.txt   13320
Mailing Address 12276 WILKINS AVENUE ROCKVILLE MD 20852
Business Address 12276 WILKINS AVENUE ROCKVILLE MD 20852 301-770-3099
NABI BIOPHARMACEUTICALS (Filer) CIK: 0000072444 (see all company filings)

IRS No.: 591212264 | State of Incorp.: DE | Fiscal Year End: 1226
Type: 8-K | Act: 34 | File No.: 001-35285 | Film No.: 111282438
SIC: 2836 Biological Products, (No Diagnostic Substances)